Malignant pleural mesothelioma

被引：0

作者：

Hesdorffer, M. E. ^{[1
,2
]}

Leinwand, J. ^{[3
]}

Taub, R. N. ^{[4
]}

机构：

[1] Columbia Univ, Mesothelioma Ctr, New York, NY 10027 USA

[2] Mesothlioma Appl Res Fdn, Washington, DC USA

[3] Columbia Univ, New York, NY USA

[4] Columbia Univ, Med, New York, NY USA

来源：

JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH | 2007年 / 37卷 / 03期

关键词：

Biphasic; cordectomy; EPP; IMRT; MARS; Pemetrexed;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Malignant mesothelioma is a rare tumour that arises from the mesothelial surfaces of the pleura, peritoneum, pericardium, or the tunica vaginalis, with the pleura the most commonly affected site. By 2015, mesothelioma is expected to result in approximately 2,000 deaths per annum in the UK. In the US, there are approximately 3,000 cases of malignant mesothelioma diagnosed yearly. Mesothelioma historically carried a dismal prognosis but, with the advent of new treatment options and translational research, progress is being made. This article will address pleural mesothelioma.

引用

页码：232 / 237

页数：6

共 39 条

[1] Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest [J].

Ahamad, A ;

Stevens, CW ;

Smythe, WR ;

Liao, ZX ;

Vaporciyan, AA ;

Rice, D ;

Walsh, G ;

Guerrero, T ;

Chang, J ;

Bell, B ;

Komaki, R ;

Forster, KM .

CANCER JOURNAL, 2003, 9 (06) :476-484

[2] CURRENT APPROACH TO MALIGNANT MESOTHELIOMA OF THE PLEURA [J].

AISNER, J .

CHEST, 1995, 107 (06) :S332-S344

[3] Anti-mesothelial markers in sarcomatoid mesothelioma and other spindle cell neoplasms [J].

Attanoos, RL ;

Dojcinov, SD ;

Webb, R ;

Gibbs, AR .

HISTOPATHOLOGY, 2000, 37 (03) :224-231

[4] Activity of chemotherapy and immunotherapy on malignant mesothelioma: a systematic review of the literature with meta-analysis [J].

Berghmans, T ;

Paesmans, M ;

Lalami, Y ;

Louviaux, I ;

Luce, S ;

Mascaux, C ;

Meert, AP ;

Sculier, JP .

LUNG CANCER, 2002, 38 (02) :111-121

[5] The interaction of asbestos and smoking in lung cancer: A modified measure of effect [J].

Berry, G ;

Liddell, FDK .

ANNALS OF OCCUPATIONAL HYGIENE, 2004, 48 (05) :459-462

[6] Pleural biopsy: A reliable method for determining the diagnosis but not subtype in mesothelioma [J].

Bueno, R ;

Reblando, J ;

Glickman, J ;

Jaklitsch, MT ;

Lukanich, JM ;

Sugarbaker, DJ .

ANNALS OF THORACIC SURGERY, 2004, 78 (05) :1774-1776

[7] Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma [J].

Ceresoli, GL ;

Locati, LD ;

Ferreri, AJM ;

Cozzarini, C ;

Passoni, P ;

Melloni, G ;

Zannini, P ;

Bolognesi, A ;

Villa, E .

LUNG CANCER, 2001, 34 (02) :279-287

[8]

Corson Joseph M, 2004, Thorac Surg Clin, V14, P447

[9] The use of chemotherapy in patients with advanced malignant pleural mesothelioma: A systematic review and practice guideline [J].

Ellis, Peter ;

Davies, Angela M. ;

Evans, William K. ;

Haynes, Adam E. ;

Lloyd, Nancy S. .

JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (06) :591-601

[10]

Gazdar Adi F, 2003, Clin Lung Cancer, V5, P177, DOI 10.3816/CLC.2003.n.031

← 1 2 3 4 →